Mirae Asset Global Investments
ONC

Mirae Asset Global Investments’s BeOne Medicines Ltd ONC Stock Holding History

Mirae Asset Global Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.63M Buy
33,808
+10,068
+42% +$2.97M 0.01% 449
2026
Q1 		$7.05M Sell
23,740
-18,467
-44% -$5.98M 0.02% 457
2025
Q4 		$12.8M Sell
42,207
-609
-1% -$199K 0.04% 359
2025
Q3 		$14.6M Buy
42,816
+38,992
+1,020% +$11.8M 0.05% 306
2025
Q2 		$926K Buy
3,824
+374
+11% +$91.7K ﹤0.01% 850
2025
Q1 		$922K Buy
3,450
+62
+2% +$14.5K ﹤0.01% 831
2024
Q4 		$620K Sell
3,388
-357
-10% -$72.9K ﹤0.01% 916
2024
Q3 		$818K Sell
3,745
-428
-10% -$77K ﹤0.01% 861
2024
Q2 		$608K Buy
+4,173
New +$643K ﹤0.01% 886
2023
Q2 		– Sell
-11,166
Closed -$2.41M – 2715
2023
Q1 		$2.41M Buy
+11,166
New +$2.68M 0.01% 1122
2022
Q4 		– Sell
-12,148
Closed -$1.64M – 2613
2022
Q3 		$1.64M Sell
12,148
-79,743
-87% -$13.7M ﹤0.01% 1236
2022
Q2 		$14.9M Sell
91,891
-6,748
-7% -$1.05M 0.04% 464
2022
Q1 		$18.6M Sell
98,639
-15,832
-14% -$3.37M 0.04% 459
2021
Q4 		$31M Sell
114,471
-21,803
-16% -$7.36M 0.07% 331
2021
Q3 		$49.5M Sell
136,274
-22,300
-14% -$7.29M 0.13% 205
2021
Q2 		$54.4M Sell
158,574
-1,400
-0.9% -$464K 0.15% 176
2021
Q1 		$55.7M Buy
159,974
+53,520
+50% +$17.7M 0.19% 135
2020
Q4 		$27.5M Buy
106,454
+9,535
+10% +$2.63M 0.1% 241
2020
Q3 		$27.8M Buy
96,919
+52,074
+116% +$12.2M 0.14% 169
2020
Q2 		$8.45M Buy
44,845
+1,013
+2% +$165K 0.05% 368
2020
Q1 		$5.4M Sell
43,832
-17,005
-28% -$2.66M 0.04% 420
2019
Q4 		$10.1M Buy
60,837
+1,431
+2% +$238K 0.06% 351
2019
Q3 		$7.27M Buy
+59,406
New +$7.89M 0.05% 387
2019
Q2 		– Sell
-1,652
Closed -$218K – 1422
2019
Q1 		$218K Buy
+1,652
New +$223K ﹤0.01% 1257

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Mirae Asset Global Investments's ONC Position: Q2 2026 in Review

Mirae Asset Global Investments increased its BeOne Medicines Ltd (ONC) stake by 42% in Q2 2026, buying an estimated $2.97M and bringing the position to 33,808 shares worth $9.63M. The position accounts for 0.01% of the portfolio, ranked #449.

Mirae Asset Global Investments first reported a position in ONC in Q1 2019 and has held it in 24 quarters since. The position peaked at $55.7M in Q1 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Mirae Asset Global Investments held 33,808 shares of BeOne Medicines Ltd worth $9.63M as of Q2 2026.
  • Mirae Asset Global Investments bought 10,068 BeOne Medicines Ltd shares in Q2 2026, an estimated $2.97M.
  • BeOne Medicines Ltd made up 0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #449 holding.
  • Mirae Asset Global Investments first reported a position in BeOne Medicines Ltd in Q1 2019 and has held it in 24 quarters since.
  • Mirae Asset Global Investments's BeOne Medicines Ltd position peaked at $55.7M in Q1 2021.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.